Erlichman C - Search Results

1

A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.

Bible KC, Suman VJ, Menefee ME, Smallridge RC, Molina JR, Maples WJ, Karlin NJ, Traynor AM, Kumar P, Goh BC, Lim WT, Bossou AR, Isham CR, Webster KP, Kukla AK, Bieber C, Burton JK, Harris P, Erlichman C; Mayo Phase 2 Consortium; Mayo Clinic Endocrine Malignances Disease Oriented Group. Bible KC, et al. Among authors: erlichman c. J Clin Endocrinol Metab. 2012 Sep;97(9):3179-84. doi: 10.1210/jc.2012-1520. Epub 2012 Jul 6. J Clin Endocrinol Metab. 2012. PMID: 22774206 Free PMC article. Clinical Trial.

2

Molecular markers in male breast carcinoma.

Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, Donohue JH. Rayson D, et al. Among authors: erlichman c. Cancer. 1998 Nov 1;83(9):1947-55. doi: 10.1002/(sici)1097-0142(19981101)83:9<1947::aid-cncr10>3.0.co;2-j. Cancer. 1998. PMID: 9806653

3

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.

Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Lawrence JB, et al. Among authors: erlichman c. Clin Cancer Res. 1997 Oct;3(10):1713-20. Clin Cancer Res. 1997. PMID: 9815555 Clinical Trial.

4

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Erlichman C, Boerner SA, Hallgren CG, Spieker R, Wang XY, James CD, Scheffer GL, Maliepaard M, Ross DD, Bible KC, Kaufmann SH. Erlichman C, et al. Cancer Res. 2001 Jan 15;61(2):739-48. Cancer Res. 2001. PMID: 11212277

5

Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.

Adjei AA, Mauer A, Bruzek L, Marks RS, Hillman S, Geyer S, Hanson LJ, Wright JJ, Erlichman C, Kaufmann SH, Vokes EE. Adjei AA, et al. Among authors: erlichman c. J Clin Oncol. 2003 May 1;21(9):1760-6. doi: 10.1200/JCO.2003.09.075. J Clin Oncol. 2003. PMID: 12721252 Clinical Trial.

6

A Phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer.

Adjei AA, Croghan GA, Erlichman C, Marks RS, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Bruzek LM, Atherton P, Thibault A, Palmer PA, Kaufmann SH. Adjei AA, et al. Among authors: erlichman c. Clin Cancer Res. 2003 Jul;9(7):2520-6. Clin Cancer Res. 2003. PMID: 12855626 Clinical Trial.

7

Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.

Alberts SR, Schroeder M, Erlichman C, Steen PD, Foster NR, Moore DF Jr, Rowland KM Jr, Nair S, Tschetter LK, Fitch TR. Alberts SR, et al. Among authors: erlichman c. J Clin Oncol. 2004 Dec 15;22(24):4944-50. doi: 10.1200/JCO.2004.05.034. J Clin Oncol. 2004. PMID: 15611509 Clinical Trial.

8

A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.

Dy GK, Bruzek LM, Croghan GA, Mandrekar S, Erlichman C, Peethambaram P, Pitot HC, Hanson LJ, Reid JM, Furth A, Cheng S, Martell RE, Kaufmann SH, Adjei AA. Dy GK, et al. Among authors: erlichman c. Clin Cancer Res. 2005 Mar 1;11(5):1877-83. doi: 10.1158/1078-0432.CCR-04-1769. Clin Cancer Res. 2005. PMID: 15756013 Clinical Trial.

9

Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium.

Okuno S, Maples WJ, Mahoney MR, Fitch T, Stewart J, Fracasso PM, Kraut M, Ettinger DS, Dawkins F, Erlichman C. Okuno S, et al. Among authors: erlichman c. J Clin Oncol. 2005 May 1;23(13):3069-73. doi: 10.1200/JCO.2005.00.372. J Clin Oncol. 2005. PMID: 15860865 Clinical Trial.

10

A phase II study of bortezomib in the treatment of metastatic malignant melanoma.

Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C. Markovic SN, et al. Among authors: erlichman c. Cancer. 2005 Jun 15;103(12):2584-9. doi: 10.1002/cncr.21108. Cancer. 2005. PMID: 15887220 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters